Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures

International Journal of Pharmaceutics

Volumn 180, Issue 1, 1999, Pages 31-39

  Olbrich, C ^a   Muller R H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Biodegradation; Colloidal drug carrier; Lipid; Pancreatic lipase; Solid lipid nanoparticles

Indexed keywords

CETYLPALMITIC ACID; CHOLIC ACID; COLIPASE; DRUG CARRIER; DYNASAN 116; DYNASAN 118; FATTY ACID; LIPOID E 80; NANOPARTICLE; PALMITIC ACID DERIVATIVE; POLOXAMER; POLYSORBATE 80; SURFACTANT; TRIACYLGLYCEROL LIPASE; TRIPALMITIN; TRISTEARIN; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADATION; DRUG RELEASE; ENZYME ASSAY; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL;

BIODEGRADATION, ENVIRONMENTAL; DRUG CARRIERS; LIPASE; LIPID METABOLISM; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 0345148806     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00404-9     Document Type: Article

References (19)

1. Amselm S., Domb A.J., Avling C.R. Lipospheres as a vaccine carrier system: effects of size, charge and phospholipid composition. Vacc. Res. 1:1992;383-395.
2. Bargoni A., Cavalli R., Caputo O., Fundaro A., Gasco M.R., Zara G.P. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm. Res. 15:1998;745-750.
3. Blunk T., Hochstrasser D. F., Sanchez J.-C., Müller B.W., Müller R.H. Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 14:1993;1382-1387.
4. Boltri L., Canal T., Esposito P., Carli F. Relevant factors affecting the formulation and growth of lipid nanospheres suspensions. Eur. J. Pharm. Biopharm. 41:1995;70-75.
5. Borgström B. On the interactions between pancreatic lipase and colipase and the substrate and the importance of bile salts. J. Lipid Res. 16:1975;411-417.
6. Heiati H., Tawashi R., Phillips N.C. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencapsul. 15:1998;173-184.
7. Hildebrand G.E., Dingler A., Runge S.A., Müller R.H. Medium scale production of solid lipid nanoparticles (SLN). Proc. Int. Symp. Control. Rel. Bioact. Mater. 25:1998;1283-1284.
8. Mehnert W., zur Mühlen A., Dingler A., Weyhers H., und Müller R.H. Solid lipid nanoparticles - ein neuartiger Wirkstoff - Carrier für Kosmetika und Pharmazeutika, 2. Mitteilung: Wirkstoff Inkorporation, Freisetzung und Sterilisierbarkeit. Pharm. Ind. 59:1997;511-514.
9. Müller, R.H., 1991. Colloidal Carriers for Controlled Drug Delivery and Targeting, Modification, Characterization and In Vivo Distribution. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, CRC, Boca Raton, FL.
10. Müller R.H., Mehnert W., Lucks J.S., Schwarz C., zur Mühlen A., Weyhers H., Freitas C., Rühl D. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:1995;62-69.
11. Müller R.H., Rühl D., Runge S.A. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int. J. Pharm. 144:1996;115-121.
12. Müller R.H., Weyhers H., zur Mühlen A., Dingler A., Mehnert W. Solid lipid nanoparticles - ein neuartiger Wirkstoffcarrier für Kosmetika und Pharmazeutika, 1. Mitteilung: Systemeigenschaften, Herstellung und scaling up. Pharm. Ind. 59:1997;423-427.
13. Müller, R.H., Lucks, J.S., 1996. European Patent No. 0605497.
14. Olbrich C., Mehnert W., Müller R.H. Effect of surfactant and lipid composition on the in vitro degradation time of solid lipid nanoparticles SLN™ Proc. Int. Symp. Control. Rel. Bioact. Mater. 24:1997;921-922.
15. Olbrich, C., Mehnert, W., Müller, R.H., 1998a. Development of an in vitro degradation assay for solid lipid nanoparticles. Proc. 2nd World Meeting APGI/APV, Paris, pp. 627-628.
16. Olbrich, C., Mehnert, W., Müller, R.H., 1998b. In vitro degradation properties of solid lipid nanoparticles (SLN). Proc. 2nd World Meeting APGI/APV, Paris, pp. 577-578.
17. Siekmann B., Westesen K. Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1:1992;123-126.
18. Sjostrom B., Kaplun A., Talmon Y., Cabane B. Structures of nanoparticles prepared from oil-in-water emulsions. Pharm. Res. 12:1995;39-48.
19. zur Mühlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery, drug release and release mechanism. Eur. J. Pharm. Biopharm. 45:1998;149-155.